{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.042, "exchange": "ASX", "shortName": "RESONANCE FPO", "longName": "Resonance Health Limited", "messageBoardId": "finmb_878144", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "marketState": "POSTPOST", "esgPopulated": false, "sharesOutstanding": 461150016, "bookValue": 0.023, "fiftyDayAverage": 0.0479, "fiftyDayAverageChange": -0.0058999993, "fiftyDayAverageChangePercent": -0.12317327, "twoHundredDayAverage": 0.057885, "twoHundredDayAverageChange": -0.015885, "twoHundredDayAverageChangePercent": -0.27442342, "marketCap": 19368300, "priceToBook": 1.8260869, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 946854000000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683870241, "regularMarketDayHigh": 0.042, "regularMarketDayRange": "0.042 - 0.042", "regularMarketDayLow": 0.042, "regularMarketVolume": 75140, "regularMarketPreviousClose": 0.042, "bid": 0.042, "ask": 0.044, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.042, "averageDailyVolume3Month": 160360, "averageDailyVolume10Day": 65203, "fiftyTwoWeekLowChange": 0.0020000003, "fiftyTwoWeekLowChangePercent": 0.05000001, "fiftyTwoWeekRange": "0.04 - 0.094", "fiftyTwoWeekHighChange": -0.051999997, "fiftyTwoWeekHighChangePercent": -0.5531915, "fiftyTwoWeekLow": 0.04, "fiftyTwoWeekHigh": 0.094, "earningsTimestamp": 1682653376, "earningsTimestampStart": 1682653376, "earningsTimestampEnd": 1682653376, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "symbol": "RHT.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "141 Burswood Road", "city": "Burswood", "state": "WA", "zip": "6100", "country": "Australia", "phone": "61 8 9286 5300", "fax": "61 8 9286 5399", "website": "https://www.resonancehealth.com", "industry": "Health Information Services", "industryDisp": "Health Information Services", "sector": "Healthcare", "longBusinessSummary": "Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-assisted device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also offers quantitative imaging measurements and CRO, such as quality-assured image analysis, imaging charter development, project and data management, issue resolution, site tracker and clinical trial progress report, and coordination of data flow services; biomarkers, blood, urine, and protein analytes, as well as RNA, DNA, and genotyping services; and protocol development, assessment of subject inclusion or exclusion, decisions on dose modifications, and evaluating the safety profile of a new therapy, as well as supporting primary and secondary end-points demonstrating drug efficacy services for multinational and multicenter clinical trials; and phantoms for the calibration of MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B., LLB", "age": 47, "title": "MD, Joint Company Sec. & Exec. Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 260000, "fmt": "260k", "longFmt": "260,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nicholas  Allan A.C.A., B.Com.", "title": "CFO, COO & Joint Company Sec.", "fiscalYear": 2022, "totalPay": {"raw": 225000, "fmt": "225k", "longFmt": "225,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ben  Winters", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Liesl  Ellies", "title": "Gen. Counsel & Joint Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chad  Tondut", "title": "Communications Mang. and GM of Products & Portfolio", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ajay  Nair", "title": "Gen. Mang. of Global Sales & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D.", "title": "Chief Research Scientist", "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Wenjie  Pang Ph.D.", "title": "Chief Scientific Officer \u0096 Imaging & AI", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sherif  Boulos Ph.D.", "title": "Chief Scientific Officer of Molecular", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}